Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 August 1994 | Volume 121 Issue 3 | Pages 181-186
Objective: To determine if chronic sympathetic deprivation is associated with anemia and a low erythropoietin response.
Design: Survey of the prevalence and characteristics of anemia in patients with severe primary autonomic failure.
Setting: A referral service for autonomic failure in a tertiary teaching hospital.
Patients: 84 patients with primary autonomic failure who had symptomatic orthostatic hypotension.
Intervention: Open-label trial with human recombinant erythropoietin.
Results: Anemia was present in 32 of 84 patients (38%; 95% CI, 27% to 50%). Plasma norepinephrine levels, measured in patients standing upright, were lower in the patient group with lower hemoglobin levels. Mean values in 22 patients with a hemoglobin level of less than 120 g/L were as follows: hemoglobin, 108 g/L (range, 87 to 118 g/L); hematocrit, 0.33; corrected reticulocyte counts, 0.008; mean corpuscular volume, 89 fL (89 microns3); serum iron, 16.5 µmol/L (92 µg/dL); total iron binding capacity, 43.3 µmol/L (242 µg/dL); ferritin, 184 µg/L; serum vitamin B12, 410 pmol/L (556 pg/mL); and serum folate, 22.7 nmol/L (10 ng/mL). No relation was found between serum erythropoietin and blood hemoglobin levels. In seven of nine patients with autonomic failure who had hemoglobin levels less than 120 g/L, serum erythropoietin levels decreased below the 95% confidence interval corresponding to patients with iron deficiency anemia. Therapy with recombinant erythropoietin improved mean hemoglobin levels (from 108 to 133 g/L) in all patients treated (n = 5) at relatively low doses (25 to 50 units/kg body weight, subcutaneously, three times a week).
Conclusions: Our data support the hypothesis that the sympathetic nervous system stimulates erythropoiesis in humans because anemia is a frequent occurrence in patients with severe autonomic failure and is associated with a blunted erythropoietin response.
Author and Article Information
From Vanderbilt University and the Department of Veterans Affairs Medical Center, Nashville, Tennessee.
ARTICLE
The Anemia of Primary Autonomic Failure and its Reversal with Recombinant Erythropoietin
![]()
Requests for Reprints: Italo Biaggioni, MD, Clinical Research Center, AA-3228 MCN, Vanderbilt University, Nashville, TN 37232-2195.
Acknowledgments: The authors thank Mrs. Dorothea Boemer and Jane Estrada for editorial assistance in the preparation of this manuscript.
Grant Support: In part by National Institutes of Health grants RR00095, HL14192, and HL 36984, and National Aeronautics and Space Administration grants NAGW-3854 and NCG 9-563.
This article has been cited by other articles:
![]() |
R. Freeman Neurogenic Orthostatic Hypotension N. Engl. J. Med., February 7, 2008; 358(6): 615 - 624. [Full Text] [PDF] |
||||
![]() |
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Grubb Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance Circulation, June 7, 2005; 111(22): 2997 - 3006. [Full Text] [PDF] |
||||
![]() |
C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach Hypertension, April 1, 2005; 45(4): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jacob, F. Costa, and I. Biaggioni Spectrum of Autonomic Cardiovascular Neuropathy in Diabetes Diabetes Care, July 1, 2003; 26(7): 2174 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Diedrich, J. Jordan, J. R. Shannon, D. Robertson, and I. Biaggioni Modulation of QT Interval During Autonomic Nervous System Blockade in Humans Circulation, October 22, 2002; 106(17): 2238 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Bosman, A. S. Winkler, J. T. Marsden, I. C. Macdougall, and P. J. Watkins Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy Diabetes Care, March 1, 2001; 24(3): 495 - 499. [Abstract] [Full Text] |
||||
![]() |
T. J. Montine, M. F. Beal, D. Robertson, M. E. Cudkowicz, I. Biaggioni, H. O'Donnell, W. E. Zackert, L. J. Roberts, and J. D. Morrow Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease Neurology, March 1, 1999; 52(5): 1104 - 1104. [Full Text] |
||||
![]() |
J. JORDAN, J. R. SHANNON, B. POHAR, S. Y. PARANJAPE, D. ROBERTSON, R.-M. ROBERTSON, and I. BIAGGIONI Contrasting Effects of Vasodilators on Blood Pressure and Sodium Balance in the Hypertension of Autonomic Failure J. Am. Soc. Nephrol., January 1, 1999; 10(1): 35 - 42. [Abstract] [Full Text] |
||||
![]() |
J. Shannon, J. Jordan, F. Costa, R. M. Robertson, and I. Biaggioni The Hypertension of Autonomic Failure and Its Treatment Hypertension, November 1, 1997; 30(5): 1062 - 1067. [Abstract] [Full Text] |
||||
![]() |
G. Jacob, J. R. Shannon, B. Black, I. Biaggioni, R. Mosqueda-Garcia, R. M. Robertson, and D. Robertson Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic Tachycardia Circulation, July 15, 1997; 96(2): 575 - 580. [Abstract] [Full Text] |
||||